Inflammopharmacology

, Volume 26, Issue 3, pp 851–859 | Cite as

Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway

  • Seyed Mahdi Rezayat
  • Ahmad-Reza Dehpour
  • Saeed Mohammadi Motamed
  • Maryam Yazdanparast
  • Mohsen Chamanara
  • Mousa Sahebgharani
  • Amir Rashidian
Original Article

Abstract

Aim

The aim of the present study is to investigate the protective effects of Foeniculum vulgare essential oil on intestinal inflammation through the inhibition of NF-kB pathway in acetic acid-induced rat colitis.

Methods

Acute colitis was induced by intra-rectal administration of 2 mL of diluted acetic acid (4%) solution. Two hours after the induction of colitis, 0.2% tween 80 in normal saline, dexamethasone (2 mg/kg) and F. vulgare essential oil (100, 200, 400 mg/kg) were administered to the animals by oral gavage and continued for 5 consecutive days. Assessment of macroscopic and microscopic lesions was done. MPO activity was evaluated by biochemical method. Furthermore, TNF-α activity was detected by immunohistochemistry (IHC) and the expression level of p-NF-kB p65 protein was measured by western blot analysis.

Results

Dexamethasone and F. vulgare essential oil (200, 400 mg/kg) reduced the macroscopic and microscopic lesions compared to the acetic acid group (p < 0.01, p < 0.001). In addition, these agents decreased the activity of MPO (p < 0.01, p < 0.001) and the expression of TNF-α positive cells (p < 0.05, p < 0.01, p < 0.001) in the colon tissue compared to acetic acid group. Furthermore, they inhibited acetic acid-induced expression of p-NF-kB p65 protein (p < 0.05, p < 0.001).

Conclusion

It is proposed that the anti-inflammatory activity of F. vulgare essential oil on acetic acid-induced colitis in rats may involve the inhibition of NF-kB pathway.

Keywords

F. vulgare essential oil Ulcerative colitis Acetic acid NF-kB 

References

  1. Allred D, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155–168PubMedGoogle Scholar
  2. Anwar F, Ali M, Hussain AI, Shahid M (2009) Antioxidant and antimicrobial activities of essential oil and extracts of fennel (Foeniculum vulgare Mill.) seeds from Pakistan. Flavour Fragr J 24:170–176CrossRefGoogle Scholar
  3. Atreya I, Atreya R, Neurath M (2008) NF-κB in inflammatory bowel disease. J Intern Med 263:591–596CrossRefPubMedGoogle Scholar
  4. Badgujar SB, Patel VV, Bandivdekar AH (2014) Foeniculum vulgare Mill: a review of its botany, phytochemistry, pharmacology, contemporary application, and toxicology. BioMed Res Int. doi: 10.1155/2014/842674 (Epub 2014 Aug 3)PubMedPubMedCentralGoogle Scholar
  5. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Investig Dermatol 78:206–209CrossRefPubMedGoogle Scholar
  6. Calixto JB, Campos MM, Otuki MF, Santos AR (2004) Anti-inflammatory compounds of plant origin. Part II modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Medica 70:93–103CrossRefPubMedGoogle Scholar
  7. Cho H-I, Kim K-M, Kwak JH, Lee SK, Lee S-M (2013) Protective mechanism of anethole on hepatic ischemia/reperfusion injury in mice. J Nat Prod 76:1717–1723CrossRefPubMedGoogle Scholar
  8. Choi E-M, Hwang J-K (2004) Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia 75:557–565CrossRefPubMedGoogle Scholar
  9. Deshmukh C, Veeresh B, Pawar A (2010) Protective effect of Emblica officinalis fruit extract on acetic acid induced colitis in rats. J Herb Med Toxicol 4:83–87Google Scholar
  10. Du X et al (2017) Therapeutic efficacy of carboxyamidotriazole on 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation. Int Immunopharmacol 45:16–25CrossRefPubMedGoogle Scholar
  11. Fu Y et al (2017) A novel pyrazole-containing indolizine derivative suppresses NF-κB activation and protects against TNBS-induced colitis via a PPAR-γ-dependent pathway. Biochem Pharmacol 135:126–138CrossRefPubMedGoogle Scholar
  12. Goyal N, Rana A, Ahlawat A, Bijjem KRV, Kumar P (2014) Animal models of inflammatory bowel disease: a review. Inflammopharmacology 22:219–233CrossRefPubMedGoogle Scholar
  13. Kannan N, Guruvayoorappan C (2013) Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators. Int Immunopharmacol 16:57–66CrossRefPubMedGoogle Scholar
  14. Keskin I et al (2017) Effects of Foeniculum vulgare essential oil compounds, fenchone and limonene, on experimental wound healing. Biotech Histochem 92:274–282CrossRefPubMedGoogle Scholar
  15. Khan I, Oriowo MA, Anim JT (2005) Amelioration of experimental colitis by Na-H exchanger-1 inhibitor amiloride is associated with reversal of IL-1β and ERK mitogen-activated protein kinase. Scand J Gastroenterol 40:578–585CrossRefPubMedGoogle Scholar
  16. Kim DH, Ahn YJ (2001) Contact and fumigant activities of constituents of Foeniculum vulgare fruit against three coleopteran stored-product insects. Pest Manag Sci 57:301–306CrossRefPubMedGoogle Scholar
  17. Kim KY, Lee HS, Seol GH (2017) Anti-inflammatory effects of trans-anethole in a mouse model of chronic obstructive pulmonary disease. Biomed Pharmacother 91:925–930CrossRefPubMedGoogle Scholar
  18. Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM (2013) Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol 93:185–198CrossRefPubMedPubMedCentralGoogle Scholar
  19. Kojouharoff G, Hans W, Obermeier F, Andus T, Gross V, Falk W (1997) Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107:353–358CrossRefPubMedPubMedCentralGoogle Scholar
  20. Kooti W, Moradi M, Akbari SA, Sharafi-Ahvazi N, Asadi-Samani M, Ashtary-Larky D (2015) Therapeutic and pharmacological potential of Foeniculum vulgare Mill: a review. J HerbMed Pharmacol 4:1–9Google Scholar
  21. Lee HS, Kang P, Kim KY, Seol GH (2015) Foeniculum vulgare Mill. protects against lipopolysaccharide-induced acute lung injury in mice through ERK-dependent NF-κB activation. Korean J Physiol Pharmacol 19:183–189CrossRefPubMedPubMedCentralGoogle Scholar
  22. Lv R, Qiao W, Wu Z, Wang Y, Dai S, Liu Q, Zheng X (2014) Tumor necrosis factor alpha blocking agents as treatment for ulcerative colitis intolerant or refractory to conventional medical therapy: a meta-analysis. PLoS ONE 9:e86692CrossRefPubMedPubMedCentralGoogle Scholar
  23. Lv J, Zhang Y, Tian Z, Liu F, Shi Y, Liu Y, Xia P (2017) Astragalus polysaccharides protect against dextran sulfate sodium-induced colitis by inhibiting NF-κB activation. Int J Biol Macromol 98:723–729CrossRefPubMedGoogle Scholar
  24. Mimica-Dukić N, Kujundžić S, Soković M, Couladis M (2003) Essential oil composition and antifungal activity of Foeniculum vulgare Mill. obtained by different distillation conditions. Phytother Res 17:368–371CrossRefPubMedGoogle Scholar
  25. Molodecky NA et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(46–54):e42Google Scholar
  26. Naeini A, Khosravi A, Tajbakhsh H, Ghazanfari T, Yaraee R (2009) Anticandida and immunomodulatory effects of Foeniculum vulgare mill in vitro. Daneshvarmed 16(82):7–20Google Scholar
  27. Oktay M, Gülçin İ, Küfrevioğlu Öİ (2003) Determination of in vitro antioxidant activity of fennel (Foeniculum vulgare) seed extracts. LWT-Food Sci Technol 36:263–271CrossRefGoogle Scholar
  28. Prabhu V, Guruvayoorappan C (2014) Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits. Int Immunopharmacol 18:124–134CrossRefGoogle Scholar
  29. Rashidian A, Mehrzadi S, Ghannadi AR, Mahzooni P, Sadr S, Minaiyan M (2014) Protective effect of ginger volatile oil against acetic acid-induced colitis in rats: a light microscopic evaluation. J Integr Med 12:115–120CrossRefPubMedGoogle Scholar
  30. Rashidian A et al (2016a) Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacology 24:109–118CrossRefPubMedGoogle Scholar
  31. Rashidian A, Roohi P, Mehrzadi S, Ghannadi AR, Minaiyan M (2016b) Protective effect of ocimum basilicum essential oil against acetic acid–induced colitis in rats. J Evid-Based Complement Altern Med 21:36–42CrossRefGoogle Scholar
  32. Rehman MU et al (2014) d-Limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats. Exp Biol Med 239:465–476CrossRefGoogle Scholar
  33. Rogler G (2010) Gastrointestinal and liver adverse effects of drugs used for treating IBD. Best Pract Res Clin Gastroenterol 24:157–165CrossRefPubMedGoogle Scholar
  34. Rufino AT, Ribeiro M, Sousa C, Judas F, Salgueiro L, Cavaleiro C, Mendes AF (2015) Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur J Pharmacol 750:141–150CrossRefPubMedGoogle Scholar
  35. Sands BE, Kaplan GG (2007) The role of TNFα in ulcerative colitis. J Clin Pharmacol 47:930–941CrossRefPubMedGoogle Scholar
  36. Shukla H, Dubey P, Chaturvedi R (1989) Antiviral properties of essential oils of Foeniculum vulgare and Pimpinella anisum L. Agronomie 9:277–279CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Seyed Mahdi Rezayat
    • 1
    • 2
  • Ahmad-Reza Dehpour
    • 1
    • 3
  • Saeed Mohammadi Motamed
    • 4
  • Maryam Yazdanparast
    • 3
  • Mohsen Chamanara
    • 1
  • Mousa Sahebgharani
    • 1
  • Amir Rashidian
    • 1
  1. 1.Department of Pharmacology, School of MedicineTehran University of Medical SciencesTehranIran
  2. 2.Department of Toxicology and Pharmacology, School of Pharmacy, Pharmaceutical Sciences BranchIslamic Azad University (IAUPS)TehranIran
  3. 3.Experimental Medicine Research CenterTehran University of Medical SciencesTehranIran
  4. 4.Department of Pharmacognosy, School of Pharmacy, Pharmaceutical Sciences BranchIslamic Azad University (IAUPS)TehranIran

Personalised recommendations